Good Storage Practices

GOOD STORAGE PRACTICES FOR
PHARMACEUTICALS
GOOD STORAGE PRACTICES
Good storage practices (GSP) are that part of quality
assurance that ensures that the quality of pharmaceutical
products is maintained by means of adequate control
throughout the storage thereof…
PERSONNEL..
At each storage site there should be an adequate number of
personnel to
achieve pharmaceutical quality assurance objectives.
 All personnel should receive proper training in relation to good
storage
practice, regulations, procedures and safety.
All
staff should be trained in, and observe high levels of, personal
hygiene and sanitation.
Personnelemployed in storage areas should wear suitable protective
or working garments appropriate for the activities they perform.
STORAGE AREAS..
 Precautions must be taken to prevent unauthorized persons from
entering storage areas.
 Storage areas should be of sufficient capacity to allow the orderly

storage of the various categories of materials and products, namely
starting and packaging materials, intermediates, bulk and finished
products, products in quarantine, and released, rejected, returned or
recalled products.
STORAGE AREAS..
Storageareas should be designed or adapted to ensure good storage
conditions. In particular, they should be clean and dry and maintained
within acceptable temperature limits.
Where special storage conditions are required on the label (e.g.
temperature, relative humidity), these should be provided, checked,
monitored and recorded. Materials and pharmaceutical products should be
stored off the floor and suitably spaced to permit cleaning and inspection.
STORAGE AREAS..
Storage areas should be clean, and free from accumulated waste
 and vermin. A written sanitation programme should be available
 indicating the frequency of cleaning and the methods to be used to
 clean the premises and storage areas. There should also be a written
 programme for pest control. The pest-control agents used should be
 safe, and there should be no risk of contamination of the materials
 and pharmaceutical products. There should be appropriate
 procedures for the clean up of any spillage to ensure complete
 removal of any risk of contamination.
STORAGE AREAS..
Storage areas Receiving and dispatch bays should protect materials and
products from the weather. Receipt areas should be designed and equipped
to allow containers of incoming materials and pharmaceutical products to
be cleaned, if necessary, before storage.
 Where quarantine status is ensured by storage in separate areas, these areas
must be clearly marked and their access restricted to authorized personnel.
Any system replacing physical quarantine should provide equivalent
security. For example, computerized systems can be used, provided that
they are validated to demonstrate security of access.
STORAGE AREAS..
There should normally be a separate sampling area for starting
 materials in a controlled environment. If sampling is performed in
 the storage area, it should be conducted in such a way as to prevent
 contamination or cross-contamination. Adequate cleaning procedures
 should be in place for the sampling areas.
Physical or other equivalent validated (e.g. electronic) segregation
 should be provided for the storage of rejected, expired, recalled or
 returned materials or products. The materials or products, and areas
 concerned should be appropriately identified.
STORAGE AREAS..
Highly active and radioactive materials, narcotics and other
 hazardous, sensitive and/or dangerous materials and pharmaceutical
 products, as well as substances presenting special risks of abuse, fire
 or explosion, (e.g. combustible liquids and solids and pressurized
 gases) should be stored in a dedicated area that is subject to
 appropriate additional safety and security measures.
Materials and pharmaceutical products should be handled and
 stored in such a manner as to prevent contamination, mix-ups and
 cross-contamination.
STORAGE AREAS..
Materials and pharmaceutical products should be stored in conditions
 which assure that their quality is maintained, and stock should
 be appropriately rotated. The “first expired/first out” (FEFO)
 principle should be followed.
Rejected materials and pharmaceutical products should be identified
 and controlled under a quarantine system designed to prevent
 their use until a final decision is taken.
Storage areas should provide adequate lighting to enable all operations
to be carried out accurately and safely.
MONITORING OF STORAGE CONDITIONS..
 Recorded temperature monitoring data should be available for review. The

equipment used for monitoring should be checked at suitable predetermined
intervals and the results of such checks should be recorded and retained.
Temperature mapping should show uniformity of the temperature across the
storage facility. It is recommended that temperature monitors be located in
areas that are most likely to show fluctuations.
STORAGE REQUIREMENTS..
 Comprehensive records should be maintained showing all receipts and issues

of materials and pharmaceutical products according to a specified system,
e.g. by batch number.
LABELLING AND CONTAINERS..
 All containers should be clearly labelled with at least the name of the
material, the batch number, the expiry date or retest date, the specified
storage conditions and reference to the pharmacopoeia, where applicable.
Unauthorized abbreviations, names or codes should not be used.
RECEIPT OF INCOMING MATERIALS AND PHARMACEUTICAL
PRODUCTS..
 On receipt, each incoming delivery should be checked against the relevant

purchase order and each container physically verified, e.g. by the label
description, batch number, type of material or pharmaceutical product and
quantity.
 Each container should be carefully inspected for possible contamination,

tampering and damage, and any suspect containers or, if necessary, the entire
delivery should be quarantined for further investigation.
RECEIPT OF INCOMING MATERIALS AND PHARMACEUTICAL
PRODUCTS..
 When required, samples should be taken only by appropriately trained and

qualified personnel and in strict accordance with written sampling instructions.
Containers from which samples have been taken should be labelled
accordingly.
 Following sampling, the goods should be subject to quarantine. Batch

segregation should be maintained during quarantine and all subsequent storage.
RECEIPT OF INCOMING MATERIALS AND PHARMACEUTICAL PRODUCTS..
 Materials and pharmaceutical products should remain in quarantine until an

authorized release or rejection is obtained.
 Measures should be taken to ensure that rejected materials and

pharmaceutical products cannot be used. They should be stored separately
from other materials and pharmaceutical products while awaiting destruction
or return to the supplier.
STOCK ROTATION AND CONTROL..
 Periodic stock reconciliation should be performed by comparing the actual

and recorded stocks.
 All significant stock discrepancies should be investigated as a check against

inadvertent mix-ups and/or incorrect issue.
STOCK ROTATION AND CONTROL..
 In manufacturing facilities, partly used containers of materials and pharmaceutical

products should be securely reclosed and resealed to prevent spoilage and/or
contamination during subsequent storage. Materials and pharmaceutical products from
containers which have been opened or partly used should be used up before those in
unopened containers.
 Damaged containers should not be issued unless the quality of the material has been
shown to be unaffected. Where possible, this should be brought to the attention of the
person responsible for quality control. Any action taken should be documented.
CONTROL OF OBSOLETE AND OUTDATED MATERIALS AND PHARMACEUTICAL PRODUCTS..
 All stocks should be checked regularly for obsolete and outdated materials and
pharmaceutical products. All due precautions should be observed to prevent the
issue of outdated materials and pharmaceutical products.
RETURNED GOODS..
 Returned goods, including recalled goods, should be handled in accordance with

approved procedures and records should be maintained.
 All returned goods should be placed in quarantine and returned to saleable stock
only after this has been approved by a nominated, responsible person following a
satisfactory quality re-evaluation.
DISPATCH AND TRANSPORT..
 Materials and pharmaceutical products should be transported in such a way that their
integrity is not impaired and that storage conditions are maintained.
 Special care should be exercised when using dry ice in cold chains. In addition
observing to safety precautions, it must be ensured that the materials or product does
not come in into contact with dry ice, as this may adversely affect the product
quality, e.g. by freezing.
 Where appropriate, the use of devices to monitor conditions such as temperature

during transportation is recommended. Monitoring records should be available for
review.
 Dispatch procedures should be established and documented, taking into account the
nature of the materials and pharmaceutical products concerned and any special
precautions that might be required.
 The outside container should offer adequate protection from all external influences
and should be indelibly and clearly labelled.
 Records for dispatch should be retained, stating at least:

 — the date of dispatch;
 — the customer’s name and address;
 — the product description, e.g. name, dosage form and strength (if appropriate), batch number and
 quantify;
 — the transport and storage conditions.
 All records should be readily accessible and available on request.

REFERENCES:
 1. Good trade and distribution practice (GTDP) of pharmaceutical starting materials. Geneva, World Health
Organization, 2002 (unpublished document QAS/01.014; available on request from Essential Drugs and
Medicines Policy, World Health Organization, 1211 Geneva 27, Switzerland).
 2. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Thirty-fourth report. Geneva,
World Health Organization, 1996 (WHO Technical Report Series, No. 863).
 3. Good manufacturing practices for pharmaceutical products. In: Quality assurance of pharmaceuticals. A
compendium of guidelines and related materials. Volume 2. Good manufacturing practices and inspection.
Geneva, World Health Organization, 1999; WHO Expert Committee on Specifications for Pharmaceutical
Preparations. Thirty-Fifth report. Geneva, World Health Organization, 1999 (WHO Technical Report Series, No.
885); WHO Expert Committee on Specifications for Pharmaceutical Preparations. Thirty-Sixth report. Geneva,
World Health Organization, 2002 (WHO Technical ReportSeries, No. 902)
 4. The international pharmacopoeia, 3rd ed. Vol. 1: General methods of analysis; Vol. 2: Quality specifications;
Vol. 3: Quality specifications; Vol. 4:Tests, methods, and general requirements. Quality specifications for
pharmaceutical substances, excipients, and dosage forms; Volume 5: Test and general requirements for dosage
forms. Quality specifications for pharmaceutical substances and tablets (in press). Geneva, World Health
Organization, 1979–2002.
If you would like to donate us?
Scan below and donate us 0.013$ (US dollar) (5Rs Indian rupee)
Contact: If you want PPT/PDF files, please contact below.
Email: gnccmysore@gmail.com
Telegram:+919738137533(only for Chat)

Good Storage Practices

Uploaded by

Copyright:

Good Storage Practices

Uploaded by

Document Information

Copyright

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Good Storage Practices

Uploaded by

Copyright:

What are the requirements for personnel involved in storage of pharmaceuticals?

What precautions need to be taken for storage areas?

GOOD STORAGE PRACTICES FOR

assurance that ensures that the quality of pharmaceutical

products is maintained by means of adequate control

 Storage areas should be of sufficient capacity to allow the orderly

 Recorded temperature monitoring data should be available for review. The

 Comprehensive records should be maintained showing all receipts and issues

 On receipt, each incoming delivery should be checked against the relevant

 Each container should be carefully inspected for possible contamination,

 When required, samples should be taken only by appropriately trained and

 Following sampling, the goods should be subject to quarantine. Batch

 Materials and pharmaceutical products should remain in quarantine until an

 Measures should be taken to ensure that rejected materials and

 Periodic stock reconciliation should be performed by comparing the actual

 All significant stock discrepancies should be investigated as a check against

 In manufacturing facilities, partly used containers of materials and pharmaceutical

 Returned goods, including recalled goods, should be handled in accordance with

 Where appropriate, the use of devices to monitor conditions such as temperature

 Records for dispatch should be retained, stating at least:

 All records should be readily accessible and available on request.

You might also like